These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
288 related items for PubMed ID: 30697927
1. Blood transfusion therapy for β-thalassemia major and hemoglobin E β-thalassemia: Adequacy, trends, and determinants in Sri Lanka. Mettananda S, Pathiraja H, Peiris R, Wickramarathne N, Bandara D, de Silva U, Mettananda C, Premawardhena A. Pediatr Blood Cancer; 2019 May; 66(5):e27643. PubMed ID: 30697927 [Abstract] [Full Text] [Related]
2. Health related quality of life among children with transfusion dependent β-thalassaemia major and haemoglobin E β-thalassaemia in Sri Lanka: a case control study. Mettananda S, Pathiraja H, Peiris R, Bandara D, de Silva U, Mettananda C, Premawardhena A. Health Qual Life Outcomes; 2019 Aug 08; 17(1):137. PubMed ID: 31395066 [Abstract] [Full Text] [Related]
3. Psychological morbidity among children with transfusion dependent β-thalassaemia and their parents in Sri Lanka. Mettananda S, Peiris R, Pathiraja H, Chandradasa M, Bandara D, de Silva U, Mettananda C, Premawardhena A. PLoS One; 2020 Aug 08; 15(2):e0228733. PubMed ID: 32045443 [Abstract] [Full Text] [Related]
6. A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis. Cazzola M, Borgna-Pignatti C, Locatelli F, Ponchio L, Beguin Y, De Stefano P. Transfusion; 1997 Feb 08; 37(2):135-40. PubMed ID: 9051086 [Abstract] [Full Text] [Related]
7. High transfusion in children with beta-thalassemia/Hb E: clinical and laboratory assessment of 18 cases. Torcharus K, Withayathawornwong W, Sriphaisal T, Krutvacho T, Arnutti P, Suwanasophorn C. Southeast Asian J Trop Med Public Health; 1993 Feb 08; 24 Suppl 1():96-9. PubMed ID: 7886617 [Abstract] [Full Text] [Related]
8. Efficacy of decitabine as hemoglobin F inducer in HbE/β-thalassemia. Kalantri SA, Ray R, Chattopadhyay A, Bhattacharjee S, Biswas A, Bhattacharyya M. Ann Hematol; 2018 Sep 08; 97(9):1689-1694. PubMed ID: 29740685 [Abstract] [Full Text] [Related]
9. Survival and complications in patients with haemoglobin E thalassaemia in Sri Lanka: a prospective, longitudinal cohort study. Premawardhena AP, Ediriweera DS, Sabouhanian A, Allen A, Rees D, de Silva S, Perera W, Katugaha N, Arambepola M, Yamashita RC, Mettananda S, Jiffry N, Mehta V, Cader R, Bandara D, St Pierre T, Muraca G, Fisher C, Kirubarajan A, Khan S, Allen S, Lamabadusuriya SP, Weatherall DJ, Olivieri NF. Lancet Glob Health; 2022 Jan 08; 10(1):e134-e141. PubMed ID: 34843671 [Abstract] [Full Text] [Related]
10. Clinical manifestation of beta-thalassemia/hemoglobin E disease. Fucharoen S, Ketvichit P, Pootrakul P, Siritanaratkul N, Piankijagum A, Wasi P. J Pediatr Hematol Oncol; 2000 Jan 08; 22(6):552-7. PubMed ID: 11132229 [Abstract] [Full Text] [Related]
11. Treatment and complications of thalassemia major in Guangxi, Southern China. Yin XL, Wu ZK, He YY, Zhou TH, Zhou YL, Zhang XH. Pediatr Blood Cancer; 2011 Dec 15; 57(7):1174-8. PubMed ID: 21394896 [Abstract] [Full Text] [Related]
12. An Evaluation of Bone Health Parameters in Regularly Transfused Beta-Thalassemia Major Patients. Kothimira VK, Kumar A, Richhele LR, Sood N, Gulati A. J Pediatr Hematol Oncol; 2020 Aug 15; 42(6):381-385. PubMed ID: 32011565 [Abstract] [Full Text] [Related]
13. Haemoglobin E beta thalassaemia in Sri Lanka. Premawardhena A, Fisher CA, Olivieri NF, de Silva S, Arambepola M, Perera W, O'Donnell A, Peto TE, Viprakasit V, Merson L, Muraca G, Weatherall DJ. Lancet; 2020 Aug 15; 366(9495):1467-70. PubMed ID: 16243092 [Abstract] [Full Text] [Related]
14. Seasonal variation of pretransfusion hemoglobin levels in patients with thalassemia major. Borgna-Pignatti C, Ventola M, Friedman D, Cohen AR, Origa R, Galanello R, Lindeman R, Francis S, Reverberi R, Volpato S. Blood; 2006 Jan 01; 107(1):355-7. PubMed ID: 16179377 [Abstract] [Full Text] [Related]
15. The Effect of Blood Transfusion on Growth of Patients with Hb E/β-Thalassemia. Chuansumrit A, Sirachainan N, Kitpoka P, Kadegasem P, Songdej D, Sasanakul W, Wongwerawattanakoon P. Hemoglobin; 2019 Jan 01; 43(4-5):264-272. PubMed ID: 31760834 [Abstract] [Full Text] [Related]
16. A nationwide survey of hospital-based thalassemia patients and standards of care and a preliminary assessment of the national prevention program in Sri Lanka. Premawardhana AP, Mudiyanse R, De Silva ST, Jiffry N, Nelumdeniya U, de Silva U, Lamabadusuriya SP, Pushpakumara K, Dissanayaka R, Jansz M, Rifaya I, Navarathne U, Thirukumaran V, Arambepola M, Dayanada Bandara W, Vaidyanatha U, Mendis D, Weerasekara K, De Silva N, Shantha Kumara DK, Amarasena SD, Hemantha KK, Refai MACM, Silva I, Hameed N, Rajiyah F, Mettananda S, Allen A, Weatherall DJ, Oliveri NF. PLoS One; 2019 Jan 01; 14(8):e0220852. PubMed ID: 31419232 [Abstract] [Full Text] [Related]
17. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt. El-Beshlawy A, El-Ghamrawy M, EL-Ela MA, Said F, Adolf S, Abdel-Razek AR, Magdy RI, Abdel-Salam A. Ann Hematol; 2014 Dec 01; 93(12):2045-50. PubMed ID: 25062719 [Abstract] [Full Text] [Related]
18. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan. Zaidi U, Borhany M, Ansari S, Parveen S, Boota S, Shamim I, Zahid D, Shamsi T. Transfus Med; 2015 Apr 01; 25(2):106-10. PubMed ID: 25870030 [Abstract] [Full Text] [Related]
19. Challenges of blood transfusions in β-thalassemia. Shah FT, Sayani F, Trompeter S, Drasar E, Piga A. Blood Rev; 2019 Sep 01; 37():100588. PubMed ID: 31324412 [Abstract] [Full Text] [Related]